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Synaptic connectionsThe tumor suppressor morphogen, Patched (Ptc), has an extensive homology to the Niemann–Pick-C 1
(NPC1) protein. The NPC disease is a paediatric, progressive and fatal neurodegenerative disorder thought to
be due to an abnormal accumulation of cholesterol in neurons. Here, we report that patched mutant adults
develop a progressive neurodegenerative disease and their brain contains membranous and lamellar
inclusions. There is also a signiﬁcant reduction in the number of synaptic terminals in the brain of the mutant
adults. Interestingly, feeding cholesterol to wild type ﬂies generates inclusions in the brain, but does not
cause the disease. However, feeding cholesterol to mutant ﬂies increases synaptic connections and
suppresses the disease. Our results suggest that sequestration of cholesterol in the mutant brain in the form
of membranous material and inclusions affects available pool of cholesterol for cellular functions. This, in
turn, negatively affects the synaptic number and contributes to the disease-state. Consistent with this, in ptc
mutants there is a reduction in the pool of cholesterol esters, and cholesterol-mediated suppression of the
disease accompanies an increase in cholesterol esters. We further show that Ptc does not function directly in
this process since gain of function for Hedgehog also induces the same disease with a reduction in the level of
cholesterol esters. We believe that loss of function for ptc causes neurodegeneration via two distinct ways:
de-repression of genes that interfere with lipid trafﬁcking, and de-repression of genes outside of the lipid
trafﬁcking; the functions of both classes of genes ultimately converge on synaptic connections.
© 2009 Elsevier Inc. All rights reserved.Introduction
Several recent studies have shown that Drosophila can be used as
an effective model system to understand human diseases. For
instance, ﬂy models for several neurodegenerative diseases such as
Parkinson's disease, Alzheimer's disease, Huntington's disease, Frag-
ile-X syndrome, and several spinocerebellar ataxias have been
reported (reviewed in Bonini and Fortini, 2003). Ongoing genetic
studies with Drosophila neurodegenerative disease models promise to
enhance our understanding of disease pathogenesis and generate
target lists for future investigations and drug development. Such
diseases can also be very helpful in understanding the brain itself. The
work described in this paper stems from our unexpected result that
the loss of function for patched (ptc) causes a progressive neurode-
generative disease in Drosophila.
The ptc gene encodes a seven-pass transmembrane protein and
serves as a receptor for the Hedgehog family of signaling proteins
(reviewed in Goodrich and Scott, 1998; Bhat, 1999). In humans, Ptc is
a tumor suppressor protein and the loss of function for ptc leads toll rights reserved.nevoid basal cell carcinoma, medulloblastoma, and several other
tumors and developmental defects (Hahn et al., 1996; Johnson et al.,
1996). In Drosophila, the loss of function for ptc results in defects in
neuroblast formation and identity speciﬁcation in the ventral nerve
cord, as well as defects in segmentation of the embryonic ectoderm
and headcase development (Bhat, 1996; Bhat and Schedl, 1997;
Bejsovec and Wieschaus, 1993; Shyamala and Bhat, 2002). Previous
results indicate that Ptc represses Smoothened (Smo), a G-protein-
coupled transmembrane protein and the effector of Hh-signaling,
from activating downstream target genes (Goodrich and Scott, 1998;
Bhat, 1999). In cells where such an activation of downstream genes is
required, the interaction of Hh with Ptc relieves the repression of Smo
by Ptc, thus allowing Smo to activate downstream genes (such as
wingless and also ptc itself).
Ptc has extensive homology to the Niemann Pick C 1 (NPC1)
protein. For example, both Ptc and NPC1 proteins are seven-pass
membrane proteins of similar sizes, both have sterol-sensing domains
located approximately at the middle of the protein, the two proteins
also have two of thewhat are known as permease domains (present in
MexD and AcrB bacterial proteins), placed at the C-terminal portion of
the protein; the two proteins have signiﬁcant homology in these
domains, including the transmembrane domains (Loftus et al., 1997).
However, any functional sharing between these proteins has not been
explored and it remains unknown if this structural similarity
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disease or it is just a coincidence.
The NPC disease is a fatal, inherited, paediatric, and progressive
neurodegenerative disorder thought to be due to the abnormal
accumulation of cholesterol in neurons (Blanchette-Mackie et al.,
1988; Suzuki et al., 1995; Carstea et al., 1997; Loftus et al., 1997). A
faulty cholesterol homeostasis is thought to play a role in the
development of this disease. The disease is either caused bymutations
in the NPC1 gene, which encodes a transmembrane protein (Carstea
et al., 1997; Loftus et al., 1997), or in the HE1/NPC2 gene, which
encodes a cholesterol-binding lysosomal protein (Naureckiene et al.,
2000; see also Okamura et al., 1999). The exact mechanism, by which
these proteins prevent this neurodegenerative disease, or the role of
cholesterol in the manifestation of the disease-state, is not under-
stood. While it is thought that in NPC, formation of inclusions in
neurons is causing neuronal death, resulting in a disease-state, no
direct evidence exists to link the inclusions to disease-state.
Additionally, it is not clear if the inclusions are actually caused/
constituted by cholesterol. A recent study suggests that in the case of
Huntington's disease, formation of inclusion bodies is a cellular
response to decrease the mutant protein and prevent the poisoning of
other neurons (Arrasate et al., 2004).
A mouse model for the NPC disease has also been developed
(Loftus et al., 1997), but the molecular basis for the disease is not clear
in this system as well. In Drosophila, there are two NPC1 genes,
dNPC1a and dNPC1b. Mutants for either of the two genes die at the
larval stage (Fluegel et al., 2006; Huang et al., 2005). The study from
Huang et al. (2005) reported that while the brains in these rescued
mutants were normal, the malphigian tubule (the kidney equivalent
in ﬂies) had the highest sterol accumulation and contained large
multi-lamellar inclusions. However, a recent paper by Phillips et al.
(2008) reported that null mutants for dNPC1a genemimic humanNPC
patients with progressive motor defects and reduced life span; the
brains of these mutants were reportedly contain higher levels of
cholesterol andmulti-lamellar inclusions. The reasons for discrepancy
between the earlier study by Huang et al. (2005) and this study is not
clear at this moment.
In a modiﬁer screen, we had previously isolated a hypomorphic
mutation of ptc, ptcheadless (ptchdl), which, in combination with several
alleles of ptc, produced few adult escapers (Bhat, unpublished results,
see also Shyamala and Bhat, 2002). We also found that a viable GAL4
insertion line (ptcgal4), which in combination with null alleles of ptc,
produced viable adults (Shyamala and Bhat, 2002). These ptc mutant
adults developed a progressive NPC-like neurodegenerative disease
and their brain contained lamellar inclusions. The levels of cholesterol
esters in these individuals were also reduced. We also observed a
signiﬁcant reduction in the number of synaptic terminals in the brain of
the mutant adults. Our results show that feeding cholesterol enhances
the synaptic connections and suppresses the disease; this also restores
the levels of cholesterol esters. The results further show that Ptc does
not function directly in this process but via repressing Smoothened
(Smo). Thus, the gain of function for Hedgehog also induces the same
disease, and the disease and the loss of synaptic connections in ptc
mutants can be suppressed by simultaneously reducing the dosage of
smo. These results provide novel insight into the role of synaptic
connections and their maintenance in neural diseases.
Materials and methods
Fly strains, genetics
The ptcgal4 line has been previously described. It is an insertion of
the gal4 gene in the regulatory sequence of the ptc gene. ptchdl allele
was isolated in an F1 modiﬁer screen (Bhat, unpublished; see
Shyamala and Bhat, 2002). Other stocks used: Df (2R) NP3/CyO
(ptcdf), hs-hh, smo1, ptcdf, smo1 and ptcH84, smo1. Other ptc allelesused: ptcIN108, ptcH84, ptcS2, ptcIIR87, ptcIF85, ptcIIC84, ptc9B28 and UAS-
ptc. For wild type, Oregon R, Canton-S ﬂies and white1118 were used.
For analysis, unless otherwise stated, we used ptcgal4/ptcdf. All the
experiments were done at 22 °C except for those involving Hs-hh,
which were done at 18 °C and 29 °C (see text for details).
Locomotor activity assay and determining the progression of the disease
in ptc mutants
Four Newly eclosed females and four newly eclosed males of
wild type or ptc mutants were placed in a cornmeal–agar vial and
their locomotor activity and death were recorded every three days
for four weeks. Vials were changed once in every three days. The
testing of the ﬂies for stage 1 or 2/3 defects was done by
transferring ﬂies to new vials to avoid any interference due to
stickiness in older vials. One or two trials were conducted double
blind in all experiments. For rescue of the phenotype, we used a
UAS-ptc transgene (Shyamala and Bhat, 2002). This transgene was
introduced to ptcgal4/ptcdf background and the adults were moni-
tored for the progression of the disease. Following are the details of
the staging in our locomotor assay:
Stage 1: sluggishness and difﬁculty walking, particularly affected is
the movement and coordination of the legs.
Stage 2: walking becomes unsteady, and ﬂies are unable to hold on
to smooth surfaces against gravity, they frequently fall down and
during walking and unable to get up on their legs.
Stage 3: ﬂies become paralyzed and do not move.
Please refer to the details andmovie clips shown in Supplementary
data.
Cholesterol feeding experiment I
To determine if overloading the cholesterol metabolism in wild
type would result in the formation of inclusions in the brain and cause
behavioral defects, newly eclosed wild type adults were fed with a
small amount of yeast paste containing 5% cholesterol (W/W; Sigma,
stored at−70 °C) placed on top of the food medium once a day (the
vials were changed once every day) and their locomotor activity was
monitored once a day. Cholesterol was manually mixed with yeast
paste thoroughly until detectable cholesterol crystals were not
observed. It is possible that the cholesterol is not dissolved in the
food; our idea is to make it thoroughly dispersed in the food. For EM
analysis, ﬂies fed with yeast paste with or without cholesterol for 4–
5 days were used.
Cholesterol feeding experiment II
To determine the effect of feeding cholesterol to ptc mutant ﬂies,
newly eclosed four females and four males of wild type or ptcmutants
were placed in a vial of 1% Agarose containing 1% sucrose solution. A
small amount of yeast pastewith orwithout 5% cholesterol was placed
on top of the Agarose medium (this feeding regimen in wild type also
causes inclusion formation similar to the feeding regimen in
experiment I discussed above). Flies were transferred into new vials
once every three days. The number of dead ﬂies was recorded on the
ﬁrst, ﬁfth, ninth, and fourteenth day when the experiment was
terminated. The testing of the ﬂies for stage 1 or 2/3 defects was done
in new vials.
Cholesterol (total, free and esters) measurement experiments in wild
type and ptc mutants
Wild type and ptc mutants, aged three weeks, were used in this
experiment. Three separate experiments with triplicates for wild type
313M. Gazi et al. / Developmental Biology 334 (2009) 311–323andmutant, fedwith normal food or foodwith cholesterol, were done.
Threemeasurements of each samplewere taken and then averaged. To
measure cholesterol, the Cholesterol Quantiﬁcation kit from Biovision
was used. Each sample started out with twenty heads (10 males+10
females) homogenized in 200 μL of 1% Triton X-100 in 100%
chloroform. After the procedure, the extract was dissolved in 200 μL
of reaction buffer from which 25 μL were taken for the ﬂuorometric
reaction.
Quantitative PCR (qPCR) for ptc expression
The qPCR was done in triplicates of 100 heads each for wild type
and ptcgal/ptcdf, aged 2 weeks. Note that mutant ﬂies used were not
selected for only those that show the strong phenotype, but a
collection of those that show stage 1, stage 2 and stage 3 defects.
Heads were dissected and immediately frozen in liquid nitrogen.
The total RNA was isolated using the RNAqueous kit from Ambion.
The cDNA synthesis and real-time PCR were done in the molecular
Genomics Core facility at UTMB using the SYBR Green dye. We used
the RpL32 gene as a standard. We used primers RpL32-92F
(ATCGATATGCTAAGCTGTCGCAC) and RpL32-182R (GGCATCAGA-
TACTGTCCCTTGAAG) with amplicon of 91 bp. For the ptc gene we
used primers PTC-852F (TCTCGGATCTTTACATACGCACC) and PTC-
971R (GGGACTGGAATACTGATCGCAG) with amplicon of 120 bp. For
data analysis we have used the comparative CT method (Livak and
Schmittgen, 2001). The graph shows the results as a percentage of
wild type expression level (which is 100%).
Hh-gain of function studies
Hs-hh transgenic ﬂies were raised at 18 °C and the progeny were
also kept at 18°C throughout the developmental stages. Immediately
following eclosion one set of adults were transferred to 29 °C and the
second set was kept at 18 °C. Each set contained ten vials; each vial
had four males and four females. Flies were transferred into new vials
once every three days. After three weeks, ﬂies were scored for
locomotor defects and lethality.
Cholesterol measurements in Hs-hh-gain of function ﬂies
Hs-hh ﬂies and control were either kept at 18 °C or shifted to 29 °C
immediately after eclosion. They were kept at these temperatures for
2 weeks. For each experiment 60 ﬂies total (20 ﬂies per experiment, in
triplicates) were used. The levels of cholesterol were determined
using the cholesterol measuring kit as above.
ptc, smo experiments
To determine if reducing the dosage of smo suppresses the disease,
we generated ptcdf, smo1 and ptcH84, smo1 double mutants. These
mutants were then crossed to ptcgal4and the progeny adults of the
genotype ptcdf, smo1/ptc,+ and ptcH84, smo1/ptc,+ were followed for
the progression of the disease.
Electron microscopy
Flies were ﬁxed in freshly prepared 4% paraformaldehyde and
2.5% glutaraldehyde in 1 M sodium cacodylate buffer overnight at
4 °C. The samples were treated with 1% osmium tetroxide in 1 M
sodium cacodylate buffer containing 1.5% potassium ferrocyanide
for 1 h. They were dehydrated in graded series of alcohol and
embedded in Epon, 70–90 nm thin sections were cut and stained
with 2% urinyl acetate and lead citrate. The sections were analyzed
with a transmission electron microscope. To determine if the brain
in the ptc mutant has neurodegeneration at the gross morpholog-
ical level, the brains were dissected in PBS, ﬁxed, embedded andsections were stained with 1% toluidine blue solution. These
sections were then examined under microscopy.
Adult brain staining and imaging
Adult brains were stained with an antibody against Ptc (Forbes
et al., 1996) and an antibody against Syt (Littleton et al., 1993).
Wild type or ptc mutant ﬂies were kept under the same condition
as above during the cholesterol feeding experiment. After 0 day (the
same day as the ﬂies eclosed), 8 days, and 16 days, ﬂies were
anesthetized and the brains were dissected in ice-cold PBS. The
brains were treated with 1 mg/ml Collagenase type VII in PBS for
15 min. After rinsing twice in PBS containing Triton X-100, 0.05%
(PBST) the brains were ﬁxed in 4% paraformaldehyde for 1 h. These
brains were washed in PBST, three times each for 10 min and were
blocked in 1% Normal Goat Serum (NGS) for 3 h at 4 °C. The brains
were then incubated with rabbit anti-Syt or Ptc antibody in PBST
and 10% NGS for two days at 4 °C. After 3 h of washing, the brains
were again blocked for 1 h at 4 °C and were incubated with the
secondary antibody (Alexa Fluor 488 labelled goat anti-rabbit) for
two days at 4 °C. After washing in PBST for 3 h at RT, the brains
were mounted on slides using Vectashield and analyzed under the
ApoTome Imaging System. Using the Axio Vision software, we
created the custom method for counting the number and area of Syt
staining in the brain. For regular confocal imaging, the brains were
incubated with a FITC-labelled secondary antibody after Syt
staining. To determine the number of Syt-positive connections in
ptc, smo/ptc, + ﬂies, 16-day-old ﬂies were examined.
Results
Adults mutant for ptc develop a progressive locomotor disease
We had previously isolated a mutation in the ptc gene, ptcheadless
(ptchdl; Bhat, unpublished; see Shyamala and Bhat, 2002); while ~99%
of the homozygous individuals die as late pupa with partially missing
headcases, ~1% made it to adulthood with most of them showing
headcase defects (Shyamala and Bhat, 2002). These escapers showed
aberrant locomotor activities as adults in an age-dependent manner.
We also examined individuals that are transheterozygous for a known
viable allele of ptc, ptcgal4, where the gal4 gene is inserted into the
regulatory region of ptc (Wilder and Perrimon, 1995), and ptc null
alleles or ptc deﬁciencies (ptcdf). About 3% of these individuals also
showed the same headcase defects with partially missing headcase
(Fig. 1C) as ptchdl while the remaining 97% were morphologically
normal (Fig. 1B) similar to wild type (Fig. 1A). We sought to examine
if part of the brain is missing in those individuals that have headcase
defects. The head capsule in Drosophila is generated from the eye-
antennal disc (Haynie and Bryant, 1986). We found that in these
individuals, the brain cells are not eliminated; instead, the brain
corresponding to the missing half of the headcase is located more
interiorly in the thorax (Fig. 1E). Despite this gross morphological
defect and the abnormal brain location, these ﬂies are normal when
they eclose and are fertile and reproduce (see below).
While most of the ptcgal/ptcdf ﬂies are normal when they eclose,
including those with partially missing headcase, they soon show signs
of a locomotor disease: sluggishness and difﬁculty walking, particu-
larly affected is the movement and coordination of the legs. We
designate this as stage 1 of the disease (see Supplementary data).
These locomotor defects progress (Fig. 1F), and their walking become
unsteady, and they are unable to hold on to smooth surfaces against
gravity (stage 2; see Supplementary data). About a quarter of these
ﬂies become paralyzed (stage 3, see Supplementary data) and die
between the second and the ﬁfth week. These defects were
progressive in nature and by 30 days of time, ~15% of the ﬂies were
dead, nearly 30% had stage 2/3 defects and another 20%were showing
Fig. 1. The viable ptc mutant adults show a progressive lethality as adults. Panel A is
wild type whereas panels B–C are ptcmutants, all one week old. In panel B, the mutant
has no visible morphological defects, whereas in panel C, a viable mutant adult has eye-
head capsule defects. Panel D: Cross section of the head in wild type showing the
normal brain inside the headcase. Panel E: Cross section of the head of a ptc mutant
with headcase defects, note that one half of the brain is extended into the thorax region.
Panel F: Progression of the disease/lethality was followed in 32 mutant ﬂies (16 males
and 16 females) per trial for the duration of 4 weeks. Three different trials were done.
Since all stage 2 adults progress to stage 3, these two stages are combined. Wild type
ﬂies do not show any stage 1, stage 2/3 locomotor defects or any lethality (progressive
or not) under these conditions (data not shown).
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mutant ﬂies also showed a weaker stage 1 defect. Wild type control
ﬂies showed ~2% lethality over a period of four weeks but none
exhibited any locomotor defects. The progressive lethality and the
locomotor defects are fully rescued with a ptc transgene (UAS-ptc;
ptcgal4/ptcdf), indicating that the defects are due to loss of function for
ptc. Note that the stronger ptchdl allele has grown stronger since its
isolation and now has a fully penetrant headcase defect and dies as
late pupae with perhaps additional defects (ptc is required for
multiple tissue development), we have not been able to rescue the
homozygous ptchdl pupal lethality with any of our gal4 drivers and
have not found an appropriate driver so far.
We also examined the progression of the disease in the small
percentage of the mutant individuals that show the head defects with
part of their brain stuck within the thorax. We also determined if the
mutant individuals with head capsule defects show a higher incidence
of the behavioral defects. A comparison of the frequency of incidence
and the progression of the disease between the two groups of mutant
adults reveals that the mutant adults that are normal-lookingdeveloped the disease as frequently as ﬂies with eye-headcase
defects. Similarly, the percentage of mutant adults with headcase
defects not developing any severe symptoms of the disease was the
same as the mutant adults without any morphological defects. Thus,
the above behavioral symptoms are unlikely related to any develop-
mental or head/brain morphological defects in these mutants. This
conclusion is consistent with the fact that the behavioral symptoms
are rarely observed in the mutant adults when they are born, but
develop only later and they are also progressive in nature.
We also found that ptchdl in trans to several other alleles of ptc are
viable (between 3 and 5% of such viable adults show head capsule
defects). The penetrance of the locomotor defects (stage 2) in adult
ﬂies transheterozygous for ptchdl and several different alleles of ptc
are as follows: ptchdl/ptcS2 (0%), ptchdl/ptcIIR87 (9%), ptchdl/ptcIF85 (7%),
ptchdl/ptcIIC84 (12%), and ptchdl/ptc9B28 (4%).
Adults mutant for ptc suffer from a neurodegenerative disorder
We next examined the brain sections of ptc mutants that showed
signiﬁcant locomotor deﬁcits (stage 3) by Toluidine Blue staining. For
this purpose, we used the strongest allele, ptchdl (this mutation no
longer produces homozygotes and over ptcdf is embryonic lethal; over
ptcgal, it shows aweaker locomotor defect, therefore, we have not used
this mutation extensively in this study). As shown in Fig. 2B, the brain
of ptchdlmutants (stage 2–3) had holes in several areas (long arrows),
which were absent in wild type (Fig. 2A). We did not see these holes
in the mutants when they are showing the stage 1 of the disease. We
also examined brains from ptchdl mutant individuals by EM. As shown
in Fig. 2D, we found regions of the brain with degenerating neurons
and holes (Fig. 2D, star). The brain in these individuals had droplets of
lipids (arrows), which were observed at much less frequently in wild
type (the ratio betweenwild type and the mutant is about 1:10; N=6
brains examined); these lipid droplets are also found in the weaker
ptcgal4/ptcdf ﬂies (data not shown) but only slightly more than wild
type. In this weaker allelic combination, we did not ﬁnd any
signiﬁcant holes in the brain as we saw in the stronger combination,
however, the brains of stage 3 individuals (and not stage 1) in the
weaker combination were fragile (as judged during dissection) and
somewhat smaller compared to wild type.
Ptc is expressed in the adult brain
We stained wild type adult brains with an antibody against Ptc
(Forbes et al., 1996). As shown in Figs. 3A–C, Ptc is present in a large
number of axon tracts; it is present in the dendritic ﬁbres of the
mushroom body calyx and the KC cells but the rest of the mushroom
body was negative (Fig. 3B). It is also expressed in nerve ﬁbres of the
antennal lobe, antennal nerve bundle (Fig. 3C) and secondary
neuronal projections of the retina and several other structures (data
not shown). Ptc is not present in the protocerebral bridge. We could
not stain ptcmutant brains with this antibody since our supply of this
antibody was exhausted. Since whole mount RNA in situ results are
often not reliable in a hypomorphic mutant scenario as the case here,
we examined the levels of expression of ptc RNA in the mutant using
quantitative PCR. As shown in Fig. 3E, the levels of ptc RNA in the
mutant (ptcgal/ptcdf) appears to be about 67% of the wild type. Taken
together with the result that a ptc transgene expressed from ptcgal4
fully rescues the disease in the ptcmutant (UAS-ptc; ptcgal4/ptcdf), we
conclude that the normal function of Ptc is affected in the mutant,
which then leads to the development of the disease in adults.
The brain from ptc mutant adults with the disease contain lamellar
inclusions and membranous material
To determine if the progressive locomotor deﬁcits in ptc mutant
adults indeed have a neural basis, we performed EM analysis of the
Fig. 2.Neurodegenerative disease in ptcmutant adults. Panels A and B:Wild type and stage 3mutant mid-brain sections stainedwith toluidine blue are shown; arrows indicate holes
and empty spaces in the cortex area in the mutant (in panel B). NP indicates neuropile, note the neuropile is also abnormal in this mutant brain. Panel C: EM from a wild type brain.
Panel D: EM section from stage 3mutant brain. Arrows indicate lipid droplets, which are more common in the mutant than in wild type. Star indicates neurodegenerative areas with
empty spaces with released cellular organelle from perhaps degenerating neurons.
Fig. 3. Brain expression of ptc in wild type and ptcgal/ptcdf individuals. Panels A–C are stained with an antibody against Ptc. Panel A: Ptc protein localizes to ﬁbre tracts in the brain;
this ﬁgure represents a collection of series of confocal Z-sections. Ca, calyx (small arrow). Panel B: Expression of Ptc in the calyx and Kenyon cells (KC). Panel C: Expression in the
antennal lobe and nerve. Panel D: Schematic of a frontal section. lo p, lobula plate; lo, lobula; cb, central brain. Panel E: qPCR for the expression of ptc RNA in wild type and ptc
mutants (see text for details).
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Fig. 4. Lamellar inclusions in the brain of ptc mutants: Thin section EM photomicrographs. Panels B-I are from ptcgal/ptcdf mutant ﬂies, whereas panels J–N are from ptchdl/ptcIN108.
N, nucleus. Panel A: Brain section from a wild type showing the normal neuronal morphology. Panel B: Brain section from a ptc mutant adult with stage 3 of the disease. Arrows
indicate lamellar inclusions. Panels C–H: Likely steps during the morphogenesis of the lamellar inclusions. The membrane-like processes found in the mutant (panel c) appear to
organize around a centre into amulti-layered lamellar inclusion body (panels D–H). Scale bar for a and b is 0.5 μm, for C–H it is 0.1 μm. Panels I–N: NPC and GM gangliosidosis-type of
inclusions in the ptcmutant brain. Panel I: Brain section from ptcgal4/ptcdf individual showing theNPC-like inclusionwith internal dense core. Panels J and K: NPC-like inclusions found
in the brain sections of ptchdl/ptcIN108. Panels L–N: GM2 gangliosidosis-like inclusions in the brain sections of ptchdl/ptcIN108 mutants. Scale bar is 0.5 μm. Panels O, P: Feeding
cholesterol to wild type adults leads to the formation of inclusions in the brain (arrows). Panel Q: EM section from a wild type control fed with normal food. Scale bar is 1.0 μm.
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ultrastructural level, brain sections in ﬂies (ptcgal/ptcdf) with severe
locomotor defects (about 2–3 weeks old ﬂies) showed the presence of
lamellar inclusions in neurons (Figs. 4B–H). We found that brain
sections contained 2.7–48 inclusions per 100 μm2 (the number of
sections examined per brain was nine, and ﬁve different brains;
typical were about 6 inclusions per 100 μm2). We also found brain
sections that had no inclusions, which may represent an area of the
brain not subjected to any ptc effect. Additionally, the brain in a
mutant with severe locomotor defects showed the presence of
extensive membranous material (Figs. 4C, D, E). These membranous
materials appear to be the precursors for inclusions, i.e., they appear
to organize into lamellar bodies (Figs. 4C–H). However, it appears that
not all of the membranous material eventually becomes inclusions.
Some of the inclusions in the stronger ptchdl mutants (Figs. 4I–N)
resemble those found in the brains of NPC mutant mice and humans
(Figs. 4I–K; note the dense material of unknown nature at the central
regions of the inclusions) and indiseases causedby the accumulation of
gangliosides (Figs. 4L–N), collectively called gangliosidoses (Glomset
et al., 1995; Suzuki et al., 1995; Gravel, 1995). In wild type, in mutant
ﬂies that show no locomotor defects, mutant ﬂies in their ﬁrst week, ormutant ﬂies that were rescued using a UAS-ptc transgene, we rarely
ﬁnd any inclusions (~0.3 in an area of 100 μm2, number of sections
examined is ﬁve per brain and four different brains).
Feeding cholesterol to wild type leads to the formation of inclusions
in the brain
Because of the above results, we thought that there might be an
abnormal accumulation of cholesterol in the mutant brain. While
Filipin staining is a method that has been used to show accumulation
of cholesterol, we realized that it works well in a monolayer of cells in
tissue culture but it is not reliable for the analysis of the adult brain
because of accessibility, autoﬂorescence, and the very rapid decay of
the signal. Therefore, to determine if the inclusions in the ptc mutant
brain are due to an abnormal cholesterol metabolism, we took a
different approach. We fed wild type ﬂies with yeast paste containing
5% cholesterol for one week. We reasoned that a large amount of
cholesterol might overload the system and the excess cholesterol
might accumulate in the E/L system. Indeed, feeding 5% cholesterol in
the diet resulted in the formation of membranous material and
lamellar inclusions in the brains of wild type adults (Figs. 4O and P).
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examined was six per brain and four different brains; typically these
brains had about 12 inclusions per 100 μm2). Less than one (~0.3)
inclusion/100 μm2 was found in age-matched wild type ﬂies fed
similarly with yeast paste without any cholesterol (Fig. 4Q). We
monitored these ﬂies for any locomotor and abnormal behavioral
changes. However, these wild type ﬂies fed with cholesterol did not
show a ptc-like locomotor or any other types of defects. Nor they died
prematurely. We conclude that the excess of cholesterol leads to the
formation of membranous material and lamellar inclusions in the
brain; however, their presence alone does not cause the disease-state.
By extension, it seems likely that the presence of inclusions per se in
the mutant brain is not responsible for the disease-state or causes any
type of locomotor defects.
Feeding cholesterol to ptc mutant ﬂies suppresses the disease-state
We next fed cholesterol to ptc mutant ﬂies (ptcgal/ptcdf). To
ensure that ﬂies ate only the yeast paste containing cholesterol, we
placed them in Agarose vials (instead of the corn meal food) and
the yeast paste containing 5% cholesterol was placed on top of the
Agarose medium (note that there is no endogenous synthesis of
cholesterol in Drosophila). While this is a nutrient-poor diet and
causes lethality in wild type ﬂies as well (see Fig. 5), which is likely
due to the stressful condition (see Discussion), it standardizes the
feeding experiments since ﬂies eat only the yeast paste as opposed
to eating also the corn meal ﬂy food. This allowed us to measure the
effect of cholesterol more reliably. The disadvantage is that ﬂies
start to die after two weeks (both wild type and mutant) because of
poor nutrition; therefore the ﬂies can be reliably monitored for
about two weeks. However, since the wild type do not exhibit any
locomotor defects even under this stressful condition and we
evaluate ﬂies for the three different stages of locomotor defects, we
think that the data are valid even with lethality in wild type. Thus,
the advantages outweigh the disadvantages of this method of
feeding cholesterol. We found that feeding mutant ﬂies (ptcgal/ptcdf)
with 5% cholesterol resulted in a suppression of the locomotor
defects, progression of the disease and lethality (Fig. 5; compare
normal food versus cholesterol food; note that normal food means
food without cholesterol). Feeding 10% cholesterol did not increaseFig. 5. Feeding cholesterol to mutant ﬂies suppresses the disease. Both wild type and mu
cholesterol. The ﬂies were monitored for 2 weeks. To obtain reliability in terms of ﬂies fee
somewhat of a stressful condition; note that wild type ﬂies, while show lethality under thithe survival rate, and a 1% cholesterol diet had no signiﬁcant effect.
These results were reproducible and consistent (see Discussion).
These mutant ﬂies fed with cholesterol had typically 8 inclusions
per 100 μm2 area. These inclusions in mutants (or in wild type) fed
with cholesterol, however, were much larger compared to mutants
not fed with cholesterol.
The level of cholesterol esters is reduced in ptc mutants and is restored
with cholesterol feeding
In order to explore the relationship between cholesterol and the
disease-state, we next assayed the levels of cholesterol in wild type
and the mutant at intervals of day 1, day 7 and day 14. We also
measured the levels in ﬂies fed with cholesterol. We measured the
total cholesterol, free cholesterol and cholesterol esters. We thought
that measuring the levels of cholesterol esters is particularly useful
since in NPC disease, it is thought that unesteriﬁed cholesterol
accumulates in the EL system of neurons; if the situation is similar in
ptc mutants, we would expect a reduction in the levels of cholesterol
esters in the mutant. For assaying cholesterol, we used a cholesterol
quantiﬁcation kit (Biovision). As shown in Fig. 6, several results are of
interest. First, in wild type fed with normal food (without cholester-
ol), we found a gradual increase in the levels of cholesterol, all three
forms: total, free and esters, over themeasured intervals from day 1 to
day 14 (Fig. 6). The increase in levels from day 1 and day 14 is most
pronounced in esters of cholesterol, which is about 2.5 times;
however, this increase from day 1 to day 7 is about 2 times, indicating
that the level is reaching plateau from day 7 to day 14. Second, in wild
type the levels of esters do not appear to be signiﬁcantly increased
with cholesterol feeding, although there is an increase in the free and
the total cholesterol levels (Fig. 6). This is consistent with the ﬁnding
that when wild type ﬂies are fed with cholesterol, multi-lamellar
inclusions appear in their brain in large numbers, likely a consequence
of accumulation of unesteriﬁed cholesterol in the E/L system. This also
suggests a tight regulation of levels/formation of cholesterol ester in
wild type and also a similarity to the NPC disease in vertebrates.
Third, the levels of esters are signiﬁcantly reduced in the mutant
from day 1 itself, with about half the levels in wild type. The levels of
esters appear to reach a plateau in the mutant by day 7 since there is
not much difference between day 7 and day 14 in the levels oftant ﬂies (ptcgal/ptcdf) were fed with either yeast paste or yeast paste containing 5%
ding cholesterol, we had to design a special feeding method (see text), which creates
s condition, do not show any stage 1, 2 or 3 locomotor defects as the mutant ﬂies.
Fig. 6. The level of cholesterol esters is reduced in ptcmutant heads but is restored upon feeding cholesterol. Wild type and mutant (ptcgal/ptcdf) ﬂies were fed with normal food or
food with cholesterol and the levels of cholesterol (total, free and esters) were quantiﬁed at day 1, day 7 and day 14 (see text for details).
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difference is the maximum at day 14, nearly 2.5 times, whereas at day
1 or day 7, the differences are much less (see Fig. 6). Fourth, with
cholesterol feeding to mutants, the levels of cholesterol increase
signiﬁcantly and by day 14, it is slightly more than the level in wild
type (Fig. 6). These results show that in the mutant, the levels of
esteriﬁed cholesterol is reduced, however, feeding cholesterol
restores the level in mutants. Since there is an increase in the level
of total cholesterol as well, we cannot be certain that the rescue
observed is only due to an increase in the esters, although it is more
likely that esters are responsible.
Synaptotagmin positive terminals are signiﬁcantly reduced in the ptc
mutant brain
Given the above results, we decided to examine the mutant brains
with an antibody against Drosophila Synaptotagmin I (Syt) to
determine if the synaptic terminals are affected in their brain.
Synaptic function is known to mediate neuronal survival during
development (Nguyen et al., 2001). Pre-synaptic proteins such as
Synuclein have been directly implicated in neurodegenerative
diseases (Surguchov et al., 2001). Pre-synaptic nerve terminals are
enriched with pre-synaptic vesicles and Syt is localized to these
vesicles, where it is one of the principal proteins. Syt appears to play
an important role in both the exocytosis and endocytosis of these pre-
synaptic vesicles (Sudhof and Rizo, 1996; Nicholson-Tomishima and
Ryan, 2004). Thus, an active pre-synaptic nerve terminal is enriched
for Syt and we reasoned that Syt staining using an anti-Syt antibody
(Littleton et al., 1993) should give us a measure of the synaptic
connectivity in the brain.
We selected the dendritic-rich calyx (ca) and the protocerebral
bridge (pr br) to evaluate Syt-positive terminals inmutant brains. This
is due to the fact that Ptc is present in the calyx but not in the pr br
(see Fig. 3) and thus they provide an excellent test structure (calyx)
and an internal control (pr br). Furthermore, unlike the central
complex, which is a large area in the brain, both the calyx and the pr br
are discrete structures and therefore the synaptic connections can be
reliably quantiﬁed. Using a Zeiss ApoTome microscope and the
Axiovision computer program,we counted the number of Syt-positive
“areas” and the μm2 of the counted Syt “areas” in each slice-frame
across the calyx and the pr br of Syt-stained adult brains. Wild typeﬂies fed with normal food (yeast paste), wild type ﬂies fed with yeast
paste containing cholesterol, ptc mutant ﬂies fed with normal yeast
paste, and ptcmutant ﬂies fed with yeast paste containing cholesterol
were examined. We also examined wild type and mutant ﬂies that
were 0-days old (the same day the ﬂies were eclosed), 8-days old, and
16-days old, grown in Agarose with yeast paste that had either
cholesterol or no cholesterol.
As shown in Fig. 7, several ﬁndings are of interest. In wild type, we
found that the number of Syt-positive areas is the highest soon after
eclosion (~1300) and decreases by eight days (~800) and further
decreases by 16 days (~600). However, the Syt-positive areas in the pr
br increase from about 300 when eclosed to ~450 by eight days but
drops to ~300 by 16 days. This may be due to changes in synaptic
density. While we observed a decrease in the Syt areas in the calyx in
8-day-old wild type ﬂies fed with cholesterol (from ~1000 to 900),
there was an up-regulation in 16-day-old ﬂies with cholesterol
feeding (from ~670 to 800). In the pr br, however, the differences
were not very signiﬁcant with or without cholesterol, although
cholesterol seems to increase the number slightly in 16-day-old ﬂies.
In the ptcmutant, we found a decrease in the number of Syt areas
in the calyx even in newly eclosed ﬂies (Fig. 7). By 8 days, the number
was decreased to ~700 (compared to ~825 in wild type) and to 400 by
16 days (versus ~700 in wild type). However, the numbers in pr br are
not signiﬁcantly affected in the ptc mutant brain, though there is a
slight decrease by 16 days of age. With cholesterol feeding, the
number of Syt areas in the calyx increased slightly in 8 days, but this
increase or a block in the decrease was most pronounced by 16 days.
The pr br did not show any signiﬁcant difference with or without
cholesterol.
However, the strength of the Syt-positive areas (as measured by
the μm2 of the areas), followed a more complex pattern, perhaps
indicative of the synaptic density, but in general, showed an
increase with cholesterol both in wild type and the mutant (Fig. 7).
The strength was also enhanced in the pr br with cholesterol in
wild type; however, the effect was less pronounced in the ptc
mutant and there was not much effect in 16-day samples in the
mutant. Representative examples to illustrate these results are
shown in Figs. 7A–D for 0-day, Figs. 7A–I for 8-day and Figs. 7A–H
for 16-day time periods. These results also indicate that the loss of
function for ptc does not affect Syt expression per se. It must be
noted that in some instances, there is a decrease in the number of
Fig. 7. Syt-positive synaptic terminals are negatively affected in ptcmutant (ptcgal/ptcdf) brains and feeding cholesterol restores the number. Upper histograms showing the number
of synaptic connections (Syt-positive areas) as well as the μm2 of counted areas in the calyx (red) and pr br (yellow). In lower panels, the brains are stained with Syt antibody and
imaging of the calyx and the pr br was done by confocal microscopy. NF, normal food; Ch, food with cholesterol.
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day 7, WT cholesterol-fed ﬂies in Fig. 7). It seems possible that this
represents an increase in synaptic density (see also below at the EM
level) with cholesterol, which is particularly pronounced in wild
type. Also, since this particular mutant combination does not show
any obvious neurodegeneration, the reduction in Syt therefore is
unlikely due to a loss of neurons per se; moreover, feeding
cholesterol rescues the loss of Syt connections in the mutant.
We next sought to examine synaptic connections in the brain of
mutant individuals using EM. We were unable to exactly pinpoint the
calyx and the pr br in the brain by EM (there is no EM atlas available
for the ﬂy brain). Instead, we decided to examine the central brain
area to see if there is any difference in the synaptic connections
between wild type and the mutant with and without cholesterol
feeding. While the precise location of the EM section in this region
between samples is not accurate (it will be impossible to perfectly
match), we tried to focus as best as we can on the same area and level.
We took ﬂies that were 3 weeks old, both wild type and mutants
(ptcgal/ptcdf), raised under the same condition, fed with either normal
food or food with 5% cholesterol. The mutant ﬂies were all showing
the stage 3 of the disease and the experiments were all done at the
same time. As shown in Fig. 8, a signiﬁcant decrease in the synaptic
number in the brains of ptc mutants (Fig. 8B) compared to wild type
(Fig. 8A) was observed. The number was much higher in the brains of
ptc mutant ﬂies fed with cholesterol. The number of synaptic
connections and the density also appears to be higher in wild type
ﬂies fed with cholesterol. At this point, we do not know the
signiﬁcance of an increase in synaptic density; on the other hand, it
is difﬁcult to envision that synaptic density will have no relevance to
the functional aspect of a synaptic connection. This is an area that
needs to be explored further. We also note that EM examination ofmutant ﬂies that do not show stage 2/3 of the disease have on the
average about 70 (plus or minus 5) connections in the same region
(data not shown), suggesting that these ﬂies also likely suffer from
loss of synaptic connections. These results are consistent with the Syt
staining results and thus argues that the Syt staining and quantiﬁca-
tion using our procedure is a reliable way to determine synaptic
number and perhaps density as well.
Ptc functions via regulating Smoothened to repress the disease
We next wanted to determine if Ptc functions directly and
independent of Smo or via regulating Smo. The canonical way Ptc
signaling works is that Ptc represses Smo from activating downstream
genes. An interaction of Hh with Ptc relieves this repression of Smo by
Ptc. Smo then triggers the activation of downstream genes (Goodrich
and Scott, 1998; Bhat, 1999). Accordingly, gain of function Hh induces
the same phenotypes as loss of function Ptc. Therefore, if Ptc functions
via repressing Smo from activating downstream genes that would
otherwise cause the neurodegenerative disease, the same ptc-
phenotype is likely produced by a gain of function hh. If the role of
Ptc is direct, say via vesicular trafﬁcking of neurotransmitters (Ptc is
present in vesicles and has been implicated in vesicular trafﬁcking of
Smo, see Martin et al., 2001; Strutt et al., 2001), altering the activity of
hh is unlikely to cause a neurodegenerative disease. The caveat here is
that a high level of Hh might titrate out Ptc and still can cause the
disease.
When adults that carry the hh transgene under the control of heat
shock 70-gene promoter (Hs-hh) were continuously cultured at 29 °C,
these individuals developed the same locomotor defects as ptcmutant
adults (Fig. 9A). Moreover, as shown in Fig. 8E, EM examination of
brain sections from these individuals revealed that their neurons had
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n=5, from four brains); the number of synaptic connections was also
negatively affected in Hs-hh ﬂies raised at 29 °C (Fig. 9H). In the
control ﬂies where the Hs-hh ﬂies were raised at 18 °C, we found 1.3–
9.3 inclusions per 100 μm2 (n=5, from two brains), however, the
synaptic connections were the same as in wild type (data not shown).
Age-matched wild type ﬂies kept at 29 °C under the same condition
and the same way as Hs-hh did not have inclusions (Fig. 8F) and the
number of synaptic connections was marginally lower compared to
wild type kept at room temperature (Fig. 8H).
We further examined if the levels of cholesterol is affected in gain
of function hh. As shown in Fig. 9B, we found that Hs-hh ﬂies kept at
29 °C had approximately half the levels of cholesterol esters compared
to similarly kept wild type ﬂies. There is also a signiﬁcant reduction in
the total and free cholesterol in these Hs-hh ﬂies compared to wild
type. At 18 °C, we observed an unexplained spike in the levels in Hs-
hh ﬂies compared to wild type (Fig. 9B). Since ﬂies do poorly at 29 °C
when they are grown under stressful agarose-only media conditions,
we did not perform rescue experiments in Hs-hh ﬂies with cholesterol
feeding.
That Ptc does not play a direct role is also indicated by our ﬁndings
that ﬂies transheterozygous for ptcS2 (an allele that carries mutationFig. 8. The number of synaptic connections is negatively affected in ptc mutant (ptcgal/ptcd
photomicrographs. Arrow indicates synaptic connections, star indicates lamellar inclusions
Panels C and D: Brains from wild type and the ptcmutant raised on food containing cholest
Wild type control ﬂies (for the Hs-hh experiment) raised at 29 °C for twoweeks. Hs-hh and w
High magniﬁcation EM of a ﬂy synapse with synaptic vesicles (V). Panel H: Synaptic connein the sterol-sensing domain of Ptc; Strutt et al., 2001), and ptcgal4, or
ptcS2 and ptchdl, do not show any signiﬁcant locomotor or brain
defects. Moreover, the above result that ptc loss of function defects
can be induced in hh gain of function individuals at any time in adult
life by simply shifting them to 29 °C indicates that the defects in ptc
mutants are not due to any developmental abnormality.
We also sought to obtain further evidence that Ptc functions via
regulating Smo in the brain. Therefore, we examined the effect of
reducing the dosage of smo in ptc mutant background. As shown in
Fig. 10A, reducing the dosage of smo signiﬁcantly suppressed the
death rate of ptc mutants. Consistent with this, the synaptic
connections as well as the density (areas) were also up regulated in
ptc, smo/ptc, + adults (Figs. 10B and C).
Discussion
Here, we show that loss of function for ptc causes a neurodegen-
erative disease that has similarity to the NPC disease in vertebrates.
This involvement of Ptc in a neurodegenerative disease deﬁnes a
novel role for Ptc. The similarity to the NPC disease is consistent with
the fact that NPC1 and Ptc share signiﬁcant sequence homology. Our
results also show that the loss of function for Ptc results in a reductionf) brains and feeding cholesterol restores the number. Representative thin section EM
. Panels A and B Brains from wild type and the ptc mutant raised on normal food (NF).
erol (Ch). Panel E: Brain from Hs-hh individuals shifted to 29 °C for two weeks. Panel F:
ild type control ﬂies (panels E and F) raised at 29 °C were fed with normal food. Panel G:
ctions per 100 μm2.
Fig. 9. Locomotor defects and levels of cholesterol in Hh gain of function ﬂies: Panel A:
Locomotor defects and lethality in Hs-hh ﬂies kept at 29 °C at the end of a three-week
period. Panel B: Wild type and Hs-hh ﬂies raised at 18 °C and 29 °C were fed with
normal food and the levels of cholesterol (total, free and esters) were quantiﬁed at the
end of two weeks (see text for details).
Fig. 10. Smoothened suppresses the progression of the disease and enhances the
synaptic terminals in the ptcmutant. Panel A: Suppression of the locomotor defects and
lethality in ptc mutants (ptcgal/ptcdf) by reducing the dosage of smo. Histograms in
panels B and C show the number of synaptic connections (Syt-positive areas) as well as
the μm2 of counted areas in the calyx (red) and pr br (yellow). The data for these graphs
were obtained using an ApoTome microscope.
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progressively affects the number of Syt-positive synaptic connections
in such structures as the dendritic-rich calyx of the brain. The fact that
levels of cholesterol esters, and the number of connections in the
mutant brain can be restored by feeding cholesterol, and that the
disease can be suppressed by feeding cholesterol argues a primary
role for cholesterol esters and synaptic connections in the progression
of the disease. These results are also supported by the EM data that the
number of connections are reduced in the mutant brain, which can be
restored by feeding cholesterol. These results also reveal a role for
cholesterol esters in forming and or maintaining synaptic connec-
tions, either directly or indirectly. Moreover, our results clearly show
that inclusions per se are not the problem since wild type ﬂies can
have the inclusion but that does not cause the disease. These, we
believe, are novel results and shed new insight into the basic science
of neurodegenerative diseases in general. Our work also demonstrates
new tools to analyze the adult brain that should generally be
applicable in adult brain development and functional studies.
What is the relationship between Ptc and NPC1?
There are two NPC1 genes in Drosophila, NPC1a and NPC1b. The Ptc
protein shares signiﬁcant homology to the NPC1 proteins in Droso-
phila or to the vertebrate NPC1 protein. Two previous studies showed
that null mutants for NPC1a die as ﬁrst instar larvae, but these mutant
larvae can be rescued to adulthood by feeding them cholesterol
(Fluegel et al., 2006; Huang et al., 2005). The study from Huang et al.
(2005) reported that while the brain in these rescued mutants were
normal, the malphigian tubule (the kidney equivalent in ﬂies) had the
highest sterol accumulation and contained large multi-lamellar
inclusions. These inclusions were strikingly similar to what we have
found in the brain of ptc mutants. Moreover, in NPC disease, it is
thought that unesteriﬁed cholesterol accumulates in the E/L system.
Our results indicate that there is a reduction in the pool of esteriﬁed
cholesterol. These results suggest that the cholesterol metabolism is
affected in both NPC disease and ptc mutants.
These results further suggest that NPC1 genes in ﬂies may play a
smaller role in the brain. This possibility is consistent with the more
recent results by Phillips et al. (2008). These authors reported that
null mutants for dNPC1a gene mimic human NPC patients withprogressive motor defects and reduced life span; the brains of these
mutants reportedly contain higher levels of cholesterol and multi-
lamellar inclusions. The reasons for this discrepancy between the
earlier study by Huang et al. (2005) and this study by Phillips et al.
(2008) is not clear at this moment; it is also not clear if there is any
redundancy between dNPC1b and dNPC1a.
What is the relationship between ptc and dNPC1? We have
observed that ptc mutant individuals that are also heterozygous for
NPC1a (ptc/ptc; NPC1a/+) do not show an enhancement of the
disease (data not shown). While we have not examined if the double
mutants between ptc and dNPC1 mutants show an enhanced
neurodegenerative phenotype, it may be that one needs to eliminate
also both NPC1 genes (dNPC1a and dNPC1b) in order to observe a
strong brain phenotype. Nonetheless, it seems likely that the ptc-
neurodegenerative disease in ﬂies is closest to the NPC disease in
vertebrates. In vertebrates, since loss of function for ptc die as
embryos, we do not know if Ptc has any role in preventing a
neurodegenerative disease; however, at least in Drosophila, Ptc may
function in the same pathway as the NPC1 proteins. Additional work is
needed to fully determine the relationship between dNPC1a and
dNPC1b as well as between dNPC1 genes and ptc.
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The role of Hh-Ptc-Smo signaling in development and disease has
been examined in many different studies over the last several years.
This study reveals that Ptc has a role in preventing a neurodegener-
ative disease. This disease is not due to a strange allele of ptc but due
to the loss of function for ptc. We observed the disease in several
different allelic combinations of ptc, including combinations of known
loss of function alleles and deﬁciencies (which also rules out a
background-mediated locomotor defect). The phenotype can also be
rescued by a ptc transgene. Ptc is widely expressed in the adult brain,
and at the same time, the expression of Hh is restricted to mostly
olfactory lobes (data not shown), suggesting that Ptc plays a
repressive role in the development of the disease. This is also
consistent with the result that a gain of function for Hh causes the
same disease as the loss of function for ptc. Moreover, the fact that
inducing Hh in the brain at any point in the adult life will cause the
disease indicates that the disease in the loss of function for ptc is not
due to some developmental abnormality. Our results with Hs-hh also
indicate that Ptc functions indirectly via repressing Smo. This
conclusion is consistent with the result that reducing the dosage of
smo alleviates the disease.
Lamellar inclusions and the neurodegenerative disease in ptc mutants
It is thought that in NPC disease, formation of inclusions in neurons
causes neuronal death, which results in a disease-state. However, no
direct evidence exists to link the inclusions to disease-state. A
previous study suggests that in the case of Huntington's disease,
formation of inclusion bodies is a cellular response to decrease the
mutant protein and prevent the poisoning of other neurons (Arrasate
et al., 2004). Therefore, formation of such inclusions is a good thing for
neurons in slowing down the disease. Our results show that the
inclusions in the brain of ptc mutants is due to cholesterol: feeding a
large amount of cholesterol to wild type ﬂies causes formation of
inclusions in the brain. This also indicates that the presence of
inclusions in the brain of ptc mutants is indeed due to an aberrant
metabolism or accumulation of cholesterol in neurons. We have
attempted to quantify the number of inclusions in the entire brain in
our EM experiments. However, we discovered that this is a difﬁcult
proposition for several reasons. First is the fact that there are no serial
section EMmaps of the ﬂy brain and it is nearly impossible to pinpoint
the precise location within the brain to be able to compare between
brains of different genotypes, conditions and age. Second, the
inclusions were not uniformly spread in the brain; therefore, we
were concerned that our quantiﬁcation might be misleading. The only
way to avoid these two problems and be able to give a precise
quantiﬁcation of inclusions between brains is to do serial EM sections
of the entire brain and count the number of non-overlapping
inclusions in each brain.
To perform serial EM sections of an entire brain, we made the
following calculations. Each EM section is about 100 nm thick and we
need to cut about 1500 sections to cover the entire brain. The area of
the each section is about 150,000 μm2. In order to reliably examine the
section for lamellar inclusions, we need to examine the sections at a
magniﬁcation of 5000 times. At this magniﬁcation each image will
cover 300 μm2 of an area. This means that we need to take 500 images
to cover one entire section at this magniﬁcation. Thus, the total
number of images one would have to take to examine an entire brain
is 1500×500=750,000. This is not practical given that we will have
to section a minimum of 3 brains for each sample. Therefore, our
quantiﬁcation of inclusions should be considered approximations and
may or may not be representative of the entire brain. However, we
want to point out that our quantiﬁcation of synaptic connections from
EM photomicrographs is somewhat of a different scenario since the
synaptic connections are generally spread in a uniform fashion withinthe neuropile (and the brain overall). Therefore, the error due to
imprecision of the location, though still exists, it is at a much lower
level. Nevertheless, the quantiﬁcation of the synaptic connections
using EM should be again treated as an approximation. Thus, we
resorted to examining the number of Syt-positive connections in a
discrete structure such as the calyx using the Apotome microscopy
between different samples of the brain, a muchmore accurate analysis.
How does Ptc signaling prevent the development of the disease?
Because of the technical difﬁculty with quantifying inclusions
between brain samples (see above), we focused on examining
synaptic connections in a discrete structure such as the calyx, where
we can quantify the number of Syt-positive terminals using our newly
developed method and draw meaningful conclusions. Our results
indicate that loss of synaptic terminals is a major contributor to the
disease-state. In ptc mutants, there is a signiﬁcant reduction in the
Syt-positive synaptic connections. One can argue that the loss of
synaptic connections is due to the degenerative disease. However, our
results show that loss of synaptic connections and the disease-state in
ptc mutants can be suppressed by feeding cholesterol; cholesterol
appear to prevent the loss of the synaptic connections and also the
progression of the disease.
Normally, esteriﬁed cholesterol (LDL) is taken up inside the cell via
endocytosis by the endosomal/lysosomal (E/L) system and de-
esteriﬁed in lysosomes; it is then re-esteriﬁed in the cytoplasm and
then stored or sent to other cellular components. For instance, the
most prominent characteristic of the NPC disease at the cellular level
is the blockade of intracellular transport of LDL-derived cholesterol
between the E/L compartment and the plasmamembrane resulting in
the accumulation of unesteriﬁed cholesterol in the E/L system
(Blanchette-Mackie et al., 1988; Suzuki et al., 1995; Vanier and
Suzuki, 1998). This blockade of cholesterol transport appears to be the
cause for the formation of inclusion bodies in neurons of NPC human
patients or NPC mice. Additionally, the ﬁnding that the gene
corresponding to NPC2 encodes a ubiquitously-expressed cholester-
ol-binding lysosomal protein, known as HE1 (Naureckiene et al.,
2000), further supports a role for cholesterol in the disease. On the
other hand, in human NPC patients, a combination of diet and
cholesterol-lowering drugs had no beneﬁcial effect (Schiffmann,
1996). Therefore, the nature of cholesterol involvement in the genesis
of the disease is not known.
Our results suggest that one of the consequences of loss of function
for ptc is the accumulation of cholesterol in the cytoplasm leading to
the formation of inclusions and membranous material. Furthermore,
there is a progressive loss of synaptic connections in the mutant brain.
Thus, one possibility is that in ptc mutants, cholesterol becomes
limiting, and this leads to a loss of synaptic connections. This is
supported by the fact that feeding cholesterol to wild type or mutant
ﬂies increases the connections and in mutants, feeding cholesterol
suppresses the disease. Results from a few previous studies are also
consistent with this possibility. For example, an in vitro study
suggested that cholesterol promotes formation of synapses (Mauch
et al., 2001). We can also observe this in the adult ﬂy brain. Moreover,
apoE has long been suspected to be involved in neurodegenerative
loss of synaptic plasticity in the Alzheimer's disease (Herz and Beffert,
2000). Furthermore, the e4 mutant in the gene for ApoE, an important
cholesterol transport protein, is associated with an increased risk of
late-onset Alzheimer's disease; this mutant isoform of the protein is
less able to promote neurite outgrowth than other apoE isoforms
(Strittmatter et al., 1993). It is not clear, however, if cholesterol
promotes synapse formation by directly inﬂuencing the membrane
property (i.e., ﬂuidity), as a structural component, via regulating gene
activity, or via the synthesis of neurosteroids. A decrease in the
available cholesterol may increase the ﬂuidity of the plasma
membrane of synaptic terminals and make synaptic connections
323M. Gazi et al. / Developmental Biology 334 (2009) 311–323structurally unstable. Alternatively, limiting amounts of cholesterol
may affect gene expression or the synthesis of neurosteroids,
contributing to the disease-state. We also want to point out that the
suppression of the disease with cholesterol is not complete. Thus, we
think that loss of function for ptc causes neurodegeneration via two
distinct ways: 1) de-repressing genes that interfere with lipid/
cholesterol trafﬁcking, and 2) de-repressing genes outside of the lipid
trafﬁcking; the functions of both classes of genes ultimately converge
on synaptic connections.
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